Status and phase
Conditions
Treatments
About
BACKGROUND The newly developed anthrax vaccine GC1109 has been proven safe and effective in preclinical studies.
OBJECTIVE
STUDY DESIGN
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 4 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal